Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial-Reference-Cited by-同舟云学术

Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial

Published:2001-09 Issue:9283 Volume:358 Page:702-710
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bath Philip MW,Lindenstrom Ewa,Boysen Gudrun,De Deyn Peter,Friis Pal,Leys Didier,Marttila Reijo,Olsson Jan-Edwin,O'Neill Desmond,Orgogozo Jean-Marc,Ringelstein Bernd,van der Sande Jan-Jacob,Turpie Alexander GG

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Antithrombotic therapy for cerebrovascular disorders;Sherman;Chest,1995

2. European strategies for early intervention in stroke;Cerebrovasc Dis,1996

3. Antithrombotic and thrombolytic therapy for ischemic stroke;Albers;Chest,1998

4. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials;Sandercock;J Neurol Neurosurg Psychiatry,1993

5. The International Stroke Trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke;Lancet,1997

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke;European Stroke Journal;2024-02-21

2. Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration;JAMA Neurology;2024-02-01

3. Early Antithrombotic Therapy in Acute Ischemic Stroke;Journal of Neuroendovascular Therapy;2024

4. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial;BMJ Neurology Open;2023-06

5. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis;BMJ;2022-07-04